oligonucleotide therapy for Angelman syndrome (Exicure)

N/A

Report date: 2025/01/26 16:03:13
NME

Base Information

Drug Nameoligonucleotide therapy for Angelman syndrome (Exicure)
Drug Alias Namespherical nucleic acids program (Exicure)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAngelman Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesExicure Inc
China Registration ClassN/A

Develop Information

Active CompaniesExicure IncIpsen SA
Inactive CompaniesN/A
Active IndicationsAngelman Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A